Depression Clinical Trials in Los Angeles

Showing 1-20 of 231 trials

Better Sleep Study

NCT06139861

The overall aim of this proposal is a confirmatory efficacy trial sufficiently powered and designed to test the hypothesis that improving the relationship between biological circadian timing and waketime, a novel modifiable target, improves depression outcomes in a subgroup of adolescents with depression and a misaligned relationship between biological circadian timing and waketime utilizing a cognitive-behavioral sleep intervention.

Depression in AdolescenceDelayed Sleep Phase

Children's Hospital Los Angeles200 participantsStarted Mar 2024

Los Angeles, California, United States

RECRUITINGPhase 3< 1 mile

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

NCT06564818

The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD.

Major Depressive Disorder

Cybin IRL Limited220 participantsStarted Dec 2024

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +43 more locations

Better Sleep Study

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

Depression Trials in Other Cities

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

Personalized Brain Stimulation to Treat Chronic Concussive Symptoms

Enhancing Mental and Physical Health of Women Veterans

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

PD, PK, and Safety of ALTO-203 in Patients With MDD

A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

Zelquistinel in the Treatment of Adults With Major Depressive Disorder

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder

Supporting Peer Interactions to Expand Access to Digital Cognitive Behavioral Therapy for Spanish-speaking Patients

Cognitive Training as an Adjunct to Ketamine in Real-world Clinics

Other Conditions in Los Angeles